Authors:
Stewart, WC
Sharpe, ED
Day, DG
Kolker, AE
Konstas, AGP
Lee, WH
Rieser, JC
Chopra, H
Holmes, KT
Citation: Wc. Stewart et al., Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension, J OCUL PH T, 16(3), 2000, pp. 251-259
Authors:
Stewart, WC
Kolker, AE
Sharpe, ED
Day, DG
Holmes, KT
Leech, JN
Johnson, M
Cantrell, JB
Citation: Wc. Stewart et al., Factors associated with long-term progression or stability in primary open-angle glaucoma, AM J OPHTH, 130(3), 2000, pp. 274-279
Authors:
Stewart, WC
Sharpe, ED
Harbin, TS
Pastor, SA
Day, DG
Holmes, KT
Stewart, JA
Citation: Wc. Stewart et al., Brimonidine 0.2% versus dorzolamide 2% each given three times daily to reduce intraocular pressure, AM J OPHTH, 129(6), 2000, pp. 723-727
Authors:
Stewart, WC
Day, DG
Sharpe, ED
Dubiner, HB
Holmes, KT
Stewart, JA
Citation: Wc. Stewart et al., Efficacy and safety of timolol solution once daily vs timolol gel added tolatanoprost, AM J OPHTH, 128(6), 1999, pp. 692-696